FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US

18,400 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 10600 - 10800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.10612Unknown Nullactive2019-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.19601x_ServiceEventPerformeractive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.20549Criticality Observationactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.15.2.5.1Initial Case Report Trigger Code Result Statusactive2024-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.15.2.5.12Therapeutic Response to Medicationactive2024-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.5.9.2Codes for MDRO and CDI Summary Data LTCFactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.5.9.3NHSNPrimaryResidentServiceTypeactive2020-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.5.9.4Codes for Denominators for Long Term Care Locations LTCFactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.5.9.5Codes for Prevention Process Measures LTCFactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.9.1NHSNReportNoEventsMDROLTCFactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.10Codes for Healthcare Personnel Influenza Vaccination (HP FLU) Summary Dataactive2019-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.11Codes for Hemovigilance (HV) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.12Codes for Intensive Care Unit (ICU) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.13Codes for Neonatal Intensive Care Unit (NICU) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.15Codes for Prevention Process and Outcome Measures (POM) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.16Codes for Specialty Care Area (SCA) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.17Codes for Vascular Access Type (Dialysis) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.18NHSNReportNoEventsICUactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.19NHSNReportNoEventsNICUactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.20NHSNReportNoEventsSCAactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.21NHSNReportNoEventsMDROactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.22NHSNReportNoEventsDialysisactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.24NHSNVascularSpecimenCollectionSiteactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.29NHSNSSIDetectionMethodactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.3NHSNLastLocationEncounterTypeCodeactive2020-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.30NHSNLOS/MENDischargeDispositionactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.31NHSNSSIDetectionMethodTypeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.32Codes for Outpatient Procedure Component Same Day Outcome Measures Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.33NHSNReportNoEventsOPCSameDayOutcomeMeasuresactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.34NHSNOPCProcedureCategoryCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.35NHSNReportNoEventsARactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.4NHSNDrugSusceptibilityTestMethodactive2020-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.40NHSN COVID19 Case Classificationactive2021-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.5NHSN Pathogen Reduced Apheresis Platelet Usageactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.50NHSNGenotypicTestInterpretationactive2024-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.6HealthcarePersonnelTypeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.7NHSNInfluenzaVaccinationSettingactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.8Codes for Antimicrobial Resistance Option (ARO) Summary Dataactive2020-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.9Codes for Antimicrobial Usage, Pharmacy (AUP) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.12.1Personal And Legal Relationship Role Typeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.21AgePQ_UCUMactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.32DIRDocumentTypeCodesactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.47ADL Result Typeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.49Residence and Accommodation Typeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.50Sensory Status Problem Typeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.51Healthcare Agent Qualifieractive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.52Encounter SCTactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.56Referral Typesactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.62Related Document (append/replace)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.66Patient Referral Act moodCodeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.68Note Typesactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.69.4Advance Healthcare Directive Categories LOINCactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.1NHSNEncounterTypeCodeactive2019-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.10NHSNASAClassCodeactive2019-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.11NHSNSpinalFusionLevelCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.12NHSNOccasionOfDetectionCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.13NHSNDrugSusceptibilityFindingCodeactive2020-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.15NHSNDrugSusceptibilityTestsCodeactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.16NHSNPathogenCodeactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.17NHSNProcedureCategoryCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.19NHSNHealthcareServiceLocationCodeactive2019-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.2NHSNSpinalFusionApproachCodeactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.20NHSNInfectionTypeCodeactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.3NHSNHipReplacementCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.4NHSNKneeReplacementCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.6NHSNInfectionRiskFactorsCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.7NHSNBloodStreamInfectionEvidenceTypeCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.9NHSNWoundClassCodeactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.17.4077.2.1017Closed Head and Facial Traumaactive2020-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.17.4077.2.1018Closed Head and Facial Traumaactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.134Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatmentactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.136Perforation of Uterusactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.137Uterine Windowactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.138Uterine Ruptureactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.200Anticoagulant Therapyactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.201Antithrombotic Therapy Anticoagulantactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.202Atrial Fibrillation or Flutteractive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.203Atrial Ablationactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.204Carotid Interventionactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.205Direct Thrombin Inhibitoractive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.207Discharged to Health Care Facility for Hospice Careactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.209Discharged to Home for Hospice Careactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.211Injectable Factor Xa Inhibitor for VTE Prophylaxisactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.212Hemorrhagic Strokeactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.213INRactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.214Intermittent pneumatic compression devicesactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.215LDLcactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.218Unfractionated Heparinactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.219Low Molecular Weight Heparin for VTE Prophylaxisactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.222Intravenous routeactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.223Subcutaneous routeactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.226Thrombolytic tPA Therapyactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.230Venous foot pumpsactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.232Warfarinactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.234Hemorrhagic Strokeactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.235Hemorrhagic Strokeactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.238Carotid Interventionactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.239Carotid Interventionactive2019-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.242Atrial Ablationactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.243Atrial Ablationactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.244Atrial Fibrillation or Flutteractive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.245Atrial Fibrillation or Flutteractive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.246Atrial Fibrillation or Flutteractive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.247Ischemic Strokeactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.25Single Live Birthactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.251Ischemic Stroke Embolismactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.252Ischemic Stroke Embolismactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.255General Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.256Graduated compression stockingsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.257Gynecological Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.258Hip Fracture Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.259Hip Replacement Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.26Single Live Born Newborn Born in Hospitalactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.260Intracranial Neurosurgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.261Knee Replacement Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.263Obstetrical or Pregnancy Related Conditionsactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.264Obstetrics VTEactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.27Dietary Intake Other than Human Milkactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.270Acute or Persistent Asthmaactive2022-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.271Acute or Persistent Asthmaactive2022-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.272Urological Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.279Venous Thromboembolismactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.281Laboractive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.282Cesarean Birthactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.286Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestationactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.288Medical Induction of Laboractive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.292Emergency Department Visitactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.294Decision to Admit to Hospital Inpatientactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.295Decision to Admit to Hospital Inpatientactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.296Psychiatric/Mental Health Diagnosisactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.298Psychiatric/Mental Health Diagnosisactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.299Psychiatric/Mental Health Diagnosisactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.30Human Milkactive2025-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.308Left Against Medical Adviceactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.309Patient Expiredactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.310Gynecological Surgeryactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.313Gynecological Surgeryactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.315Knee Replacement Surgeryactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.317Knee Replacement Surgeryactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.319Hip Replacement Surgeryactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.321Hip Replacement Surgeryactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.323Hip Fracture Surgeryactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.325Hip Fracture Surgeryactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.328Venous Thromboembolismactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.33Galactosemiaactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.330Venous Thromboembolismactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.331Urological Surgeryactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.333Urological Surgeryactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.335Obstetrical or Pregnancy Related Conditionsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.337Obstetrical or Pregnancy Related Conditionsactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.338Obstetrics VTEactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.340Obstetrics VTEactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.344Intracranial Neurosurgeryactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.346Intracranial Neurosurgeryactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.348General or Neuraxial Anesthesiaactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.35Galactosemiaactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.361General Surgeryactive2021-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.365General Surgeryactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.367Cesarean Birthactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.369Cesarean Birthactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.37Parenteral Nutritionactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.38Parenteral Nutritionactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.384Medical Induction of Laboractive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.393Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestationactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.395Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestationactive2025-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.400Low Riskactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.401Delivery Proceduresactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.418Classical Cesarean Birthactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.419Classical Cesarean Birthactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.421Classical Cesarean Birthactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.422Myomectomyactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.423Statin Allergenactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.424Nonelective Inpatient Encounteractive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.473Medical Reason For Not Providing Treatmentactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.75Neonatal Intensive Care Unitactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.76Single Live born Newbornactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.78Galactosemiaactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.79Parenteral Nutritionactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.87Discharge To Acute Care Facilityactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.93Patient Refusalactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1434.1047Skin Melanoma pT1active2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.100Injectable Fluorouracilactive2020-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.101Trastuzumab and Biosimilarsactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.102Breast Canceractive2020-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.103HER2 Presence in Tissueactive2020-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.104Depression Screening for Adultactive2020-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.105Long Acting Opioidsactive2024-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.106High Fiber Supplement or Diet Educationactive2020-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.107Standardized Assessment Tools for Dyspneaactive2020-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.108Nausea or Vomiting Assessmentactive2020-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.109Pancreatic Canceractive2020-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.110Pancreatic Canceractive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.111Audio Visual Telehealth Encounteractive2020-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.112Telephone Encounteractive2020-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.113Telehealth Emergency Department or Initial Inpatientactive2020-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.114Karnofsky Performance Statusactive2020-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.115Referral to Hospice Careactive2020-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.116Referral to Palliative Careactive2020-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.117Assessment Scale for Dyspneaactive2020-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.118Nausea or Vomiting Assessmentactive2020-10hl7